Weight-Loss Surgeries Drop 25 Percent As Americans Opt For GLP-1 Medications

A study shows a 25.6 per cent decline in weight-loss surgeries as more Americans turn to GLP-1 medications like Wegovy and Zepbound. Despite their popularity, high costs and side effects may lead to treatment discontinuation.